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phy were the main diagnostic tool, however, other diag-
nostic modalities (C-MRI and C-CT) were helpful in
offering further diagnostic information and surgical plan-
ning. Of the 16 patients, 8 patients were operated on as
an urgent or emergency. Among the 16 patients, 9
(56.25%) patients were operated for Myxoma excision.
right ventricular sarcoma (1), metastactic leiomyosar-
coma (2), metastatic sacral sarcoma (1), and metastatic
renal cell carcinoma (2), and Bachets disease (1). There
were no in-hospital mortality and all patient had symp-
tomatic improvements.
Conclusion: Cardiac tumours still represent a chal-
lenging condition. Our review shows that metastatic
tumours represent almost 50% of all our cardiac tumours.
Appropriate available diagnostic modalities is crucial, as
currently prompt complete surgical removal is the only
therapeutic & palliative option and offers best chances
of survival.
http://dx.doi:10.1016/j.jsha.2013.03.038
Oral anticoagulation throughout pregnancy in
patients with mechanical heart valve prosthesis:
Safe alternatives
Ahmed Hassouna, Ahmed Teima, Ayman Ammar,
Yasser Elnahas, Mohamed Badawi
Objectives: Small dose of Warfarin (65 mg/day) was
suggested as being safe in pregnant patients with
mechanical heart valve prosthesis (MHVP) however; no
other oral anticoagulant (OA) alternative has been pro-
posed to cases failing to achieve their target INR. We
aimed to suggest the alternative use/shift of those cases
to our previously reported safe (OA) Phenindione
(6100 mg/day) and to compare both regimens.
Methods: Eighty-seven females with 106 bileaflet
MHVP implanted in the aortic (10; 11.5%), mitral (58;
66.7%) or both positions (19; 21.8%) continued OA
throughout pregnancy, with restriction of daily doses to
5 mg Warfarin or 100 mg Phenindione. Patients were
allowed to cross over if failed to achieve their target
INR: 2-3.5. Aspirin (100 mg/day) was supplemented,
starting second trimester.
Results: Out of 59 patients initially receiving Warfa-
rin, 15 (25.4%) shifted to Phenindione, compared to none
of 28 patients originally receiving Phenindione
(P = 0.002). Mean INR and daily OA dose for 44 patients
remaining on Warfarin and 43 patients receiving Phenin-
dione were: 2.39 ± 0.34 versus 2.25 ± 0.2 (P > 0.05) and
3.9 ± 1.07 mg versus 79.3 ± 18.5 mg; respectively. Mater-
nal complications were six cases of resolved vaginal
bleeding (6.9%). There were no cases of embryopathy
or prematurity. Fetal outcomes included 68 live births
(78.2%), seven abortions (8%), two fetal loss (2.3%); all
insignificantly related to OA dose or INR level.
Conclusion: Although 65 mg Warfarin per day can
be safe during pregnancy, yet it cannot always achieve
the target INR and 6100 mg of Phenindione can be con-
sidered as a comparatively safe alternative.
http://dx.doi:10.1016/j.jsha.2013.03.039
The aortic translocation (Nikaidoh) procedure: Ini-
tial experience
A. Elwy, A. Al Saeedi, H. Alqethamy, Y. AlFariedi,
A. Raghib, K. Alnajashi, A. Khoja, R. Di Donato
Prince Sultan Cardiac Center, Riyadh, Saudi Arabia
Objective: Midterm follow-up is analyzed after the
aortic translocation (Nikaidoh) procedure, an alternative
to the Rastelli procedure for ventriculoarterial discor-
dance, ventricular septal defect, and pulmonary stenosis
especially in cases with small or inlet VSD.
Methods: Seven patients underwent a Nikaidoh pro-
cedure at a median age of 3.3 years (0.9–9.3 years). The
native aortic valve was translocated from the right to
the left ventricular outflow tract by mobilization of the
aortic root.Four patients with coronary transfer as
the right coronary artery reimplanted as a button while
the other three patients had no coronary transfer. The
conal septum was divided in all patients. The right
ventricular outflow tract was reconstructed with valved
conduit. The median follow-up was 18 months (0.3–4
years). Left ventricular outflow tract obstruction and
aortic insufficiency were assessed by echocardiography.
Results: There were no deaths. Right ventricular to
Pulmonary artery conduit change were required in 2
patients (28.6%). No patient had any left ventricular out-
flow tract obstruction or aortic insufficiency more than
mild. All patients are doing well at last follow up.
Conclusion: The Nikaidoh is a valid alternative to
Rastelli or REV operations. It appears particularly indi-
cated in patients with TGA,VSD and LV outflow obstruc-
tion with small or inlet VSD.
http://dx.doi:10.1016/j.jsha.2013.03.040
Short-term outcome of coronary artery bypass graft
surgery in end stage renal failure dialysis-depen-
dent patients
Ahmed Ibrahim Rezk
Background: Patients with end-stage renal disease
(ESRD) requiring dialysis who undergo coronary artery
bypass graft surgery (CABG) are at significant risk for
perioperative morbidity and mortality. We describe our
own experience in such high risk subgroup of patients.
Methods: Over four years period, a retrospective
analysis of fifteen patients with dialysis-dependent renal
failure who underwent coronary artery bypass grafting.
Mean age was 55 ± 12 years. Except from one patient
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who was on peritoneal dialysis, all other patients were on
regular hemodialysis. five patients were referred to car-
diac surgery as their coronary artery disease was
detected during routine coronary angiography before
renal transplant.
Results: There was one postoperative death (in-hos-
pital mortality, 6.6%). The patient who died was suffering
from morbid obesity with severe LV dysfunction and
poor target coronary artery vessels. Three patients
underwent renal transplantation after CABG operation
and another one patient was recently operated and is
waiting for transplant. One patient was complicated with
significant perioperative MI after having LAD endartrec-
tomy and surgical reconstruction with LIMA; this was
complicated with heart failure and moderate to severe
MR. This patient had lost his chance for future renal
transplant. One patient had cerebral hemorrhage 2
months after surgery and he recovered.
Conclusions: Cardiac operations in patients with
end-stage renal disease may be performed with a fairly
low perioperative risk and the perspective of short-term
functional improvement and acceptable survival. How-
ever, careful selection is mandatory for better outcome.
http://dx.doi:10.1016/j.jsha.2013.03.041
Safe introduction of ventricular assist devices into
national clinical practice
Ahmed Al-adhami, John Payne, Roy Gardner,
Mike Higgins, Mark Petrie, Saleem Haj-yahia
Introduction: We report the first national Scottish
experience with ventricularassist- devices (VADs) in a
selected group of patients for whom short-term VADs
(ST-VADs) were used as a salvage ‘bridge-to-decision’
(BTD) and long-term VADs (LT-VADs) as a ‘bridge-to-
transplantation/recovery’ (BTT/BTR). Method: From Jan-
uary 2010–July 2012, 13 (mean-age 42.4(16–62) years)
INTERMACS I patients required emergency ST-VAD
support as BTD and 9 (meanage 35.4(16-53) years)
INTERMACS I–IV required LT-VADs as BTT/BTR.
Results: Of BTD patients, 8(61.5%) received ST-BiV-
ADs, 3(23.1%) ST-LVADs and 2(15.4%) peripheral Centr-
iMag ECMO. Nine(69.2%) survived to last follow-up:
1(7.7%) is on ST-VAD support, 5(45.5%) bridged to myo-
cardial-recovery and VADexplantation, 1(9.1%) to trans-
plantation and 2(9.1%) to LT-support. Mean durations
of ST-support, renal-support and postoperative ICU-stay
were 31.3(2–110), 6.6(0–31) and 35.5(1–119) days, respec-
tively. Four(36.4%) early deaths and one after discharge.
One(7.7%) stroke, 2(15.4%) acute-limb-ischemia and
6(46.2%) re-explored. No driveline-infections or device-
failures. Cumulative survival was 57.1% at 4, 12 and 24
months postoperatively. Of LT-LVAD patients, 6(66.7%)
remain on LT-support, 1(11.1%) bridged to myocardial-
recovery and VAD-explantation, and another to trans-
plantation. Mean postoperative ICU-stay and LT-support
were 19.9(6–56) and 251.3(21–751) days, respectively.
One(1.11%) patient demised after 98 days of support,
2(22.2%) suffered LVAD-induced RV failure, 2(22.2%)
required re-exploration for bleeding and only
one(11.1%) minor superficial driveline-infection was
encountered but no device/pump failure, infection or
thrombosis. Cumulative survival was 85.7% at 4, 12 and
24 months of support.
Conclusion: With undue vigilance, complex VAD-
therapy can be integrated safely into a national program,
treating the most deranged advanced-heart-failure
patients, with low rates of complications and high rates
of myocardial-recovery.
http://dx.doi:10.1016/j.jsha.2013.03.043
Outcomes of acute myocardial infarction in type 2
diabetic yemeni patients using different methods
of treament
Ahmed Saghir Abkar Al Qudaimi
Diabetes (DM) mellitus is a chronic disease that
requires continuing medical care and patient self-man-
agement education to prevent acute complications and
to reduce the risk of long-term complications. Patient
with type 2 DM have a two to fourfold increase incidence
of disease related to atheroma.
Design and methodology: Our study is a single-
centre hospital based cohort prospective (interventional)
study.
All of the studied patients were subjected to history,
clinical evaluation,biochemical investigation. ECG and
Echocardiography were done for them. Interventional
procedures were done for all of the patients such as
PCI or CABG. Statistical analysis was done by SPSS sys-
tem. A total of 150 consecutive Yemeni patients were
included in this study. One hundred (100) patients were
diabetic and fifty (50) patients were control (non dia-
betic). The diabetic patients were treated by different
methods of insulin treatment protocol, 50 patients were
treated by insulin infusion therapy (IIT) and 50 patients
were treated by sliding scale insulin (SSI) protocol.
Anti-ischemic treatment (medications) was given to all
the cases and control groups.
Setting of the work: We recruited all patients
admitted to the intensive care units (cardiac and noncar-
diac)at Al-Thawra Teaching Hospital in Sana’a over 12
months (Jan 2007–Dec 2010).
Objectives of the study: Evaluation of the impact of
IV continuous insulin infusion technique on the outcome
of acute MI as compared to the sliding scale in diabetic
patients. Post MI surveillance of patients was also con-
ducted over the next.
Results: Male predominance was evident in this
study. Mean (±SD) Waist circumference (WC) was signif-
icantly higher in diabetic patients (95.4 ± 15.2 cm) than in
the control (90 ± 13.3 cm) (p = 0.032). Abdominal adiposity
measured as, waist to height ratio (WHtR) was found to
be more prevalent among diabetic patients (70%)
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